DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS
in the present research is shown that using information and computer technologies can automate the pharmacoeconomic evaluation of the rationality of the appointment and a forecast of efficiency of basic therapy of multiple sclerosis. Criteria of efficiency of immunomodulatory therapy of the multiple...
Main Authors: | F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2015-03-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/41 |
Similar Items
-
USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS
by: V. R. Mkrtchyan, et al.
Published: (2016-12-01) -
RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
by: F. A. Khabirov, et al.
Published: (2017-01-01) -
Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis
by: V. R. Mkrtchyan, et al.
Published: (2015-10-01) -
Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01) -
PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01)